Use access key #2 to skip to page content.
$79.24 0.90 (1.15%)
8/28/2008 4:00 PM

Genzyme Corp (GENZ)

CAPS Rating:
****

A biotechnology company dedicated to making an impact on the lives of people with serious diseases. Its product and service portfolio is focused on rare disorders, renal diseases, orthopaedics, organ transplant, and diagnostic and predictive testing.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating GENZ

Add Stock to Watchlist

What the Community Thinks

Total Members

390 Outperforms
22 Underperforms
 

All-Stars

123 Outperforms
9 Underperforms
 

Wall Street

15 Outperforms
0 Underperforms
 

Members bullish on GENZ are also bullish on:

Members bearish on GENZ are also bearish on:

Ticker Tags

Cambridge (4), Large Cap (467), Biotechnology (294), S&P 500 (479), Massachusetts (16), Nasdaq 100 (99)
Suggest a tag

Genzyme Corp At A Glance

Current Price: $79.24
Last Trade Time: 8/28/2008 4:00 PM
Open: $78.11
Previous Close: $78.34
Daily Range: $78.11 - $79.52
52-Week Range: $60.03 - $83.97
Volume: 1,369,230
Market Cap: $21.05B
P/E Ratio: 46.08
Compare Our Special Broker Offers!

Stock Trends

GENZ VS S&P 500 (SPY)

GENZ 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for GENZ

More Headlines...

Top Bull Pitch

Recs

2

Genzyme Corp (GENZ)

Avatar madiasha (< 20) Submitted: 5/03/07 1:09 PM

GENZ looks too much like a takeover target because of product and pipeline.Value is much more than present capitalization.

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

Genzyme Corp (GENZ)

Avatar StockTalking (52.66) Submitted: 8/16/07 12:03 PM

out for cash.


http://mystockmistakes.blogspot.com/

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 39 :   1 2 3 4 5 Next »

Recs

0

 (GENZ)

Avatar APNoah (49.01) Submitted: 8/19/08 6:40 AM : Outperform Start Price: $81.86 GENZ Score: -5.37

Symmetrical Continuation Triangle

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GENZ)

Avatar pk0020 (< 20) Submitted: 8/15/08 11:06 AM : Outperform Start Price: $83.73 GENZ Score: -5.49

i wish i gotten in this sooner......this guy pretty much called it and i didnt listen :( im seriously gonna follow this dude to the teeth on his next calls

http://biotechnology-stock.blogspot.com/search/label/GENZ

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GENZ)

Avatar WSMOOT19 (67.31) Submitted: 8/15/08 12:18 AM : Outperform Start Price: $83.27 GENZ Score: -5.03

26% revenue growth and no debt

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GENZ)

Avatar pjani06 (73.81) Submitted: 8/09/08 3:12 PM : Outperform Start Price: $79.17 GENZ Score: -0.45

biotech is the future and BofA securities just picked it....guess who's the tag leader on biotechnology? you guessed it, bofa securities. BUY

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (GENZ)

Avatar richardrogers4 (< 20) Submitted: 8/06/08 9:59 AM : Outperform Start Price: $78.19 GENZ Score: -0.32

Innovation

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 39 :   1 2 3 4 5 Next »

Wall Street

Results 1 - 15 of 15  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackBofASec 96.71 08/05/08 Outperform NS $76.81+3.16%+3.29%-0.13
TrackCitigroup 86.63 07/14/08 Outperform NS $77.93+1.68%+3.83%-2.15
TrackUBS 95.67 07/01/08 Outperform NS $72.33+9.55%+2.83%+6.73
TrackBernstein 82.28 05/14/08 Outperform NS $69.53+13.97%-7.67%+21.63
TrackLazardCapit 89.66 04/04/08 Outperform NS $75.09+5.53%-5.52%+11.04
TrackZacks 91.23 12/17/07 Outperform 3M $73.53+7.77%-10.26%+18.02 Toggle the visibility of 60-Second Pitch and replies
TrackWachovia 78.21 10/11/07 Outperform NS $70.00+13.20%-17.04%+30.24
TrackEdwardOwens 99.09 09/30/07 Outperform NS $61.96+27.89%-14.67%+42.56 Toggle the visibility of 60-Second Pitch and replies
TrackEveillard 93.56 09/30/07 Outperform NS $61.96+27.89%-14.67%+42.56 Toggle the visibility of 60-Second Pitch and replies
TrackFortisBank 98.32 07/09/07 Outperform NS $61.08+29.73%-14.99%+44.72
TrackLehmanBros 91.82 06/26/07 Outperform NS $64.25+23.33%-13.33%+36.66
TrackMatrix 94.59 03/15/07 Outperform NS $60.40+31.19%-6.32%+37.51
TrackStifel 97.39 01/31/07 Outperform NS $65.33+21.29%-8.72%+30.01
TrackRWBaird 88.91 01/04/07 Outperform NS $63.59+24.61%-7.82%+32.43
TrackAGEdwards 93.79 08/30/06 Outperform NS $66.46+19.23%-0.52%+19.75
TrackJimCramer 81.79 05/25/06 Outperform 3W $58.50+35.45%+1.41%+34.04

Results 1 - 15 of 15  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners